New Jersey Cancer Care and Blood Disorders (JIT) — Belleville, New Jersey

New Jersey Cancer Care and Blood Disorders (JIT) is a clinical research site located in Belleville, New Jersey, United States 07203.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

New Jersey Cancer Care and Blood Disorders (JIT) has participated in 1 clinical trials.

Therapeutic areas: Locally Advanced or Metastatic Breast Cancer.

Sponsors: Sermonix Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Jersey Cancer Care and Blood Disorders (JIT)?

New Jersey Cancer Care and Blood Disorders (JIT) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Jersey Cancer Care and Blood Disorders (JIT) conducted?

New Jersey Cancer Care and Blood Disorders (JIT) has 1 clinical trials on record. Their work covers Locally Advanced or Metastatic Breast Cancer.

Is New Jersey Cancer Care and Blood Disorders (JIT) accredited by Crixeo Health?

New Jersey Cancer Care and Blood Disorders (JIT) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Jersey Cancer Care and Blood Disorders (JIT)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.